Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery

키워드

참고문헌 (30)

1. Study), "Am J Cardiol", 2017, 25~32, 10.1016[DOI]
2. Kip KE, "The problem with composite end points in cardiovsacular studies", J Am Coll Cardiol, 51, pp.701~707 (2008)[DOI]
3. Khuri SF, "The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program", Ann Surg, 228, pp.491~507 (1998)[DOI]
4. Lee TH, "Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery", Circulation, 100, pp.1043~1049 (1999)[DOI]
5. Devereaux PJ, "Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk", CMAJ, 173, pp.627~634 (2005)[DOI]
6. Kristensen SD, "2014 ESC", ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), 2014, pp.35, 2383~2431
7. Fleisher LA, "2014 ACC", AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 64[DOI]
8. Ford MK, "Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index", Ann Intern Med, 152, pp.26~35 (2010)[DOI]
9. Botto F, "Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes", Anesthesiology, 120, pp.564~578 (2014)[DOI]
10. Bruce M. Biccard, "Myocardial Injury After Noncardiac Surgery (MINS) in Vascular Surgical Patients", Annals of Surgery, 268(2), pp.357~363 (2018), Ovid Technologies (Wolters Kluwer Health)[DOI]
11. Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators, "Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery", JAMA, 307, pp.2295~2304 (2012)[DOI]
12. Writing Committee for the VISION Study Investigators, "Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery", JAMA, 317, pp.1642~1651 (2017)[DOI]
13. Brown JC, "Highsensitivity cardiac Troponin T improves the diagnosis of perioperative MI", Anesth Analg, 125, pp.1455~1462 (2017)[DOI]
14. Aimo A, "Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis", JACC Heart Fail, 5, pp.280~286 (2017)[DOI]
15. Yang HS, "Soluble ST2 and troponin I combination: useful biomarker for predicting development of stress cardiomyopathy in patients admitted to the medical intensive care unit", Heart Lung, 44, pp.282~288 (2015)[DOI]
16. Olga Barbarash, "Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction", Annals of Laboratory Medicine, 36(4), pp.313~319 (2016), 대한진단검사의학회
17. Rossella Marino, "Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain", Annals of Laboratory Medicine, 37(2), pp.137~146 (2017), 대한진단검사의학회
18. Obokata M, "Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients", Am Heart J, 179, pp.29~41 (2016)[DOI]
19. 허미나, "Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis", Annals of Laboratory Medicine, 35(6), pp.570~577 (2015), 대한진단검사의학회
20. Mueller T, "The <TEX>$Presage^{(R)}$<", TEX> ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2, 2013, pp.13, 13~30
21. CLSI, "User verification of performance for precision and true. 2nd ed. CLSI document EP15-A2", Clinical and Laboratort Standards Institute, ~ (2005)
22. DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach", Biometrics, 44, pp.837~845 (1988)[DOI]
23. Pascual-Figal DA, "The biology of ST2: the International ST2 Consensus Panel", Am J Cardiol, 115(S7), pp.3B~7B (2015)[DOI]
24. Torborg A, "The pharmacoeconomics of routine postoperative troponin surveillance to prevent and treat myocardial infarction after non-cardiac surgery", S Afr Med J, 104, pp.619~623 (2014)[DOI]
25. van Waes JA, "Myocardial injury after noncardiac surgery and its association with short-term mortality", Circulation, 127, pp.2264~2271 (2013)[DOI]
26. Apple FS, "Cardiac Troponin Assays: guide to understanding analytical characteristics and their impact on clinical care", Clin Chem, 63, pp.73~81 (2017)[DOI]
27. Mangano DT, "Adverse outcomes after surgery in the year 2001-a continuing odyssey", Anesthesiology, 88, pp.561~564 (1998)[DOI]
28. Lindenauer PK, "Perioperative beta-blocker therapy and mortality after major noncardiac surgery", N Engl J Med, 353, pp.349~361 (2005)[DOI]
29. Farzi S, "Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery", Br J Anaesth, 110, pp.554~560 (2013)[DOI]
30. Mauermann E, "Myocardial injury after noncardiac surgery: an underappreciated problem and current challenges", Curr Opin Anaesthesiol, 29, pp.403~412 (2016)[DOI]

관련 논문AI추천